ADVERTISEMENT
Martin Nemansky, Ph.D, is Scientific Director at Pra International, Early Development Services, Bioanalytical Laboratory, The Netherlands.
Jerome Wilson and Martin Nemansky, explore some of the difficulties of implementing biomarkers during drug development.
How Virtual Media Can Save the Medical Speaker Program Sponsored By MedPoint Communications, Inc.Building Market Share Through Patient Segmentation Strategies: New Ideas and Best Practices to Enhance ROI Sponsored By Healthgrades Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset Sponsored By IntraLinks
Disclosure of Drug Promotion Expenses: How Automated Reporting and Master Data Management Can Improve Sponsored By Cegedim ARCHIVED WEBCASTS